APA (7th ed.) Citation

Avnat, E., Shapira, G., Gurwitz, D., & Shomron, N. (2022). Elevated Expression of RGS2 May Underlie Reduced Olfaction in COVID-19 Patients. Journal of Personalized Medicine, 12(9), N.PAG. https://doi.org/10.3390/jpm12091396

Chicago Style (17th ed.) Citation

Avnat, Eden, Guy Shapira, David Gurwitz, and Noam Shomron. "Elevated Expression of RGS2 May Underlie Reduced Olfaction in COVID-19 Patients." Journal of Personalized Medicine 12, no. 9 (2022): N.PAG. https://doi.org/10.3390/jpm12091396.

MLA (9th ed.) Citation

Avnat, Eden, et al. "Elevated Expression of RGS2 May Underlie Reduced Olfaction in COVID-19 Patients." Journal of Personalized Medicine, vol. 12, no. 9, 2022, p. N.PAG, https://doi.org/10.3390/jpm12091396.